Trading
Ideas
Buy Indicators
Top Buy Stocks
Popular
Pivot Bottom
Double Bottom
Golden Star
Short-term
Unlock
Golden Star
Long-term
Golden Cross
Possible Runners
Rising Trends
All Lists
Sell Indicators
Top Sell Stocks
Pivot Top
Double Top
Death Star
Short-term
Unlock
Death Star
Long-term
Death Cross
Falling Trends
All Lists
Dividends
Highest Yield
Kings
Aristocrats
Other
RSI Oversold
Top Performers
Undervalued
Popular
Tools
Research Tools
My Watchlists
Popular
My Portfolios
Beta!
Screener
AI Analyst
Popular
Heatmap
Predictions
Smart Portfolios
Calendars
Earnings Calendar
Dividend Calendar
Other
U.S. Congress Trades
Interest Calculator
Commodities
Top Online Brokers
Exchanges
News
All News
Stock Market News
Guides
Analysis & Ideas
Top Buy Stocks
Pricing & Plans
Meet
AI Analyst
Sign In
Sign in with Facebook
Sign in with Apple
or
Forgot password?
Remember me
Sign In
Creating an account or logging in means you agree to StockInvest.us
Terms of Use
and
Privacy Policy
.
See Today's Golden Star Stocks 🔥 Free for 7 Days
See Today's Golden Star Stocks 🔥 Free for 7 Days
Sign In / Sign Up
Sign In
Sign in with Facebook
Sign in with Apple
or
Forgot password?
Remember me
Sign In
Creating an account or logging in means you agree to StockInvest.us
Terms of Use
and
Privacy Policy
.
Don't have an account?
Sign Up Here
Pricing & Plans
Top Buy Stocks
Golden Star
Short-term
Unlock
Golden Star
Long-term
Trading Ideas
Buy Indicators
Top Buy Stocks
Popular
Pivot Bottom
Double Bottom
Golden Star
Short-term
Unlock
Golden Star
Long-term
Possible Runners
All Lists
Sell Indicators
Top Sell Stocks
Pivot Top
Double Top
Death Star
Short-term
Unlock
Death Star
Long-term
All Lists
Dividends
Highest Yield
Kings
Aristocrats
Other
RSI Oversold
Top Performers
Undervalued
Popular
All Lists
Tools
Research Tools
My Watchlists
Popular
Screener
AI Analyst
Popular
Predictions
Prediction Hub
Results
Top Predicted Movers
Tutorial
Heatmap
Smart Portfolios
Calendars
Earnings Calendar
Dividend Calendar
Other
Interest Calculator
U.S. Congress Trades
Commodities
Top Online Brokers
News Digest
Exchanges
News Digest
/
Ticker: AZN
Ticker: AZN
07:06am, Monday, Feb 23, 2026
FDA Gives Green Light to AstraZeneca's All-Oral Calquence-Venetoclax Combo for CLL
AstraZeneca (ST: AZN) secures FDA approval for Calquence combined with venetoclax, offering a fixed-duration oral treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma based on robust Phase III results.
Read More
07:23am, Monday, Feb 09, 2026
January Jobs Report, Inflation Updates, and Major Earnings to Steer Market Moves This Week
07:16am, Wednesday, Jan 28, 2026
London's FTSE 100 Slips Amid Healthcare and Banking Sell-Offs
09:34am, Wednesday, Dec 17, 2025
Compugen's Shares Jump as AstraZeneca Pays $65M Upfront for Rilvegostomig Royalties
07:38am, Tuesday, Dec 02, 2025
FDA Grants Priority Review to AstraZeneca's New Hypertension Drug Baxdrostat
09:02am, Wednesday, Nov 26, 2025
FDA Greenlights AstraZeneca's Imfinzi for Early-Stage Stomach and GEJ Cancers
04:44am, Tuesday, Oct 28, 2025
Novartis CEO Signals Ongoing Big-Money M&A Moves with $12B Avidity Buy
07:58am, Monday, Oct 27, 2025
Jefferies Lifts AstraZeneca to Buy, Flags $80B Sales Milestone as Within Grasp
06:26am, Thursday, Aug 07, 2025
Trump Pushes Drugmakers to Raise European Prices as U.S. Seeks Cheaper Medicine at Home
06:25am, Tuesday, Jul 22, 2025
AstraZeneca Boosts U.S. Production with New $500M Virginia Plant Amid Supply Chain Shakeup
05:26am, Monday, Mar 17, 2025
AstraZeneca Goes Big: $1 Billion Acquisition of EsoBiotec Set to Transform Cell Therapy Landscape
09:28am, Monday, Feb 03, 2025
Earnings Week Preview: Key Reports from Google, Toyota, Amazon, and More Set to Shape Market Dynamics
T
04:19am, Friday, Jan 17, 2025
AstraZeneca's Calquence Gets FDA Green Light: A Game-Changer for Non-Hodgkin Lymphoma and a Potential Windfall for Investors
05:01am, Tuesday, Nov 12, 2024
AstraZeneca Raises 2024 Forecast Amid Strategic $3.5 Billion U.S. Investment – Can It Overcome Geopolitical Headwinds?
04:20am, Monday, Nov 11, 2024
Earnings Spotlight: Key Reports to Watch This Week That Could Move the Market
S
B
03:02am, Thursday, Jul 25, 2024
AstraZeneca Raises Financial Forecasts for 2024
05:51am, Friday, Jun 14, 2024
AstraZeneca's Oncology Portfolio Advances Propel Stock Surge; CFO Optimistic on Future Revenues
08:40am, Tuesday, May 21, 2024
AstraZeneca Targets $80 Billion Revenue by 2030
YOU ARE SIGNED OUT
Sign in with Facebook
Sign in with Apple
or
Continue with Email
By continuing, you agree to StockInvest.us
Terms of Service
and acknowledge that you’ve read our
Disclaimer
&
Privacy Policy
.